Arcinova expands offering with on-site spray drying capability
Arcinova – a Quotient Sciences Business – continue to expand their service offering and as a means to do have invested in the Buchi Mini Spray Dryer B-290. The new equipment enables Arcinova to provide a new capability to their ever-growing customer base, providing flexible and efficient spray drying solutions to formulation development.
Arcinova provide end to end solutions from pre-clinical to phase IIb. The addition of the spray drier capability means that Arcinova can develop formulations of poorly soluble drugs in an amorphous form so as to enhance bioavailability of drugs. In addition, this capability to optimize particle size allows Arcinova to develop formulations specifically targeting parts of the respiratory tract from potential nasal sprays to inhalation products.
Although Arcinova’s spray drying capability is for development only, Quotient Sciences provide full GMP spray drying capabilities. Find out more here
Discover how Arcinova can help
We provide a fully integrated approach to drug development, speak to our team and discover how we can help you fast forward to market.